Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-09-29

FDA Approved: ESTRING — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for ESTRING (estradiol vaginal ring) to update its labeling for the treatment of vaginal atrophy associated with menopau…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRING (Estradiol)

Snippet

SUPPL AP for ESTRING (ESTRADIOL)